Translational Neuroscience Optimization of GlyT1 Inhibitor

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions

Cognitive Impairments Associated With Schizophrenia

Interventions

DRUG

PF-03463275

DRUG

Placebo

Trial Locations (2)

Connecticut Mental Health Center, New Haven

VA Connecticut Healthcare System, West Haven

All Listed Sponsors

collaborator

National Center for Advancing Translational Sciences (NCATS)

NIH

lead

Yale University

OTHER

NCT01911676 - Translational Neuroscience Optimization of GlyT1 Inhibitor | Biotech Hunter | Biotech Hunter